Anheuser-Busch Doubles U.S. Manufacturing Investment To $600M

St. Louis — Anheuser-Busch is increasing its investment in its U.S. operations to $600 million across 2025 and 2026.

The new figure doubles a previously announced $300 million commitment. The announcement is part of Anheuser-Busch’s ongoing Brewing Futures initiative and builds on the company’s more than 165-year legacy of investing in its people, breweries and communities.

Three key pillars

The expanded investment centers on three key pillars:

• First: creating and sustaining manufacturing jobs by increasing investments in U.S. operations to $600 million total over two years.
• Second: building the manufacturing workforce for the future by opening 15 new technical skills training centers at facilities across the country and collaborating with technical trade schools.
• Third: strengthening manufacturing career opportunities for veterans by helping former and current service members pursue manufacturing careers in the private sector.

Brewery upgrades and capacity

The investment will fund brewery upgrades, advance technology systems and increase production and packaging capabilities across the company’s brewery network. Those capabilities support production for brands including Michelob Ultra, Busch Light, Budweiser and Bud Light.

Anheuser-Busch CEO Brendan Whitworth said the investment underscores the company’s commitment to U.S. manufacturing.

“Anheuser-Busch’s $600 million investment is a testament to our unwavering commitment to the future of American manufacturing,” Whitworth said.

Technical skills training centers

The 15 new technical skills training centers will offer employees instruction in technical fundamentals, digital tools, management systems and mechanical and electrical systems.

Anheuser-Busch said it plans to upskill more than 90 percent of its manufacturing workforce over the next five years. The company has embedded its trade school collaboration into the opening of the new training centers, ensuring that curriculums address local skills gaps and community needs.

Supporting veteran career pathways

Anheuser-Busch is continuing to work with the Manufacturing Institute’s Heroes MAKE America initiative to provide former and current service members with resources to pursue careers in manufacturing.

Since announcing its industry-leading adoption of MI’s Manufacturing Readiness Badges in May 2025, Anheuser-Busch has integrated more than 20 total credentials that translate military training into skills required for manufacturing roles within its operations.

In 2026, Anheuser-Busch and MI are accelerating adoption of the Heroes MAKE America Talent Network, powered by SmartResume. The jointly developed platform is designed to make military skills and experience visible, verified and easily understood by employers.

Anheuser-Busch has embedded the tool into its career website to support veteran hiring and guide candidates through the application process. The platform has driven strong engagement, with nearly 25 percent of the more than 600 industry-wide SmartResumes completed to date originating from Anheuser-Busch’s platform.

Broader legacy

The company said investments in these areas are not new for Anheuser-Busch and represent the latest evolution in the company’s long-standing commitment to its workforce and communities.

Details about specific facility investments, including in Williamsburg, Virginia, are expected later this year.

[RELATED: Kearney Cites ‘Unpredictable’ Consumer Behavior In Beverage Outlook]

Source link

AbbVie Expands US Manufacturing with $1.4B Plant Investment

AbbVie has announced plans to invest $1.4 billion in building a pharmaceutical manufacturing campus in Durham, NC, its largest capital investment to date. 

The new 185-acre campus will integrate advanced manufacturing and laboratory technologies with artificial intelligence (AI) to support the production of AbbVie’s immunology, neuroscience, and oncology medicines, according to a news release from the global drug maker. 

This is AbbVie’s first major investment in North Carolina. The AbbVie Durham campus, located near Research Triangle Park, was selected for the strength of the region’s local workforce and its ability to support future expansion, the biopharmaceutical company added in the news release. 

Construction will begin this year, with completion expected by the end of 2028.

“Our investment in North Carolina represents a significant milestone for AbbVie as our largest capital investment to date and an important expansion of our manufacturing footprint into a new region of the United States,” Robert A. Michael, chairman and chief executive officer of AbbVie said. 

Related:International Society for Pharmaceutical Engineering Announces 2026 Facility of the Year Winners

Over the next four years, AbbVie plans to hire 734 people, including engineers, scientists, manufacturing operators and laboratory technicians. The project will also generate more than 2,000 construction jobs during campus development. 

The first phase of construction will include small volume parenteral (SVP) drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices, and employee wellness facilities.

Small volume parenterals are sterile injectable pharmaceutical products with volumes typically less than 100 mL, including vials, prefilled cartridges, and prefilled syringes containing medicines for injection or infusion. When completed, this campus will serve as AbbVie’s US center of excellence for SVP manufacturing and deliver medicines to patients in the US and worldwide.

This project is part of the pharmaceutical company’s $100 billion commitment to US research and development (R&D) and capital investments, including manufacturing, over the next decade. 

In March, AbbVie announced a $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago, IL, campus. The facilities will use advanced manufacturing technologies with AI to support the production of neuroscience and obesity medications.

Over the last several months, AbbVie has announced plans to significantly expand its API manufacturing capabilities and capacity in the US. In September 2025, AbbVie broke ground on the first phase of this investment, a new chemical synthesis facility that will enable the return of API production for some neuroscience, immunology, and oncology products from Europe and Asia to the US.

Related:2 More Pharma Companies Sell Medicines on TrumpRx

The Skyrizi and Rinvoq maker also announced plans in September 2025 to invest $70 million to expand its biologics R&D and manufacturing facility in Massachusetts.

Like more than a dozen other pharmaceutical manufacturers, AbbVie signed an agreement with the Trump Administration to lower prescription drug prices and invest in research domestically in exchange for a three-year tariff exemption. 

As part of the agreement, which AbbVie announced in January, the multinational pharmaceutical company will provide drugs through Medicaid at lower prices under most favored nation status.

Additionally, the drug maker will participate in TrumpRx, the direct-to-consumer platform, expanding its direct-to-patient offerings for medicines including Alphagan, Combigan, Humira, and Synthroid, making them available at significant discounts. The agreement to sell medications on the platform reportedly will allow patients without insurance coverage of the drugs and Medicaid access to rates comparable to other developed countries.

Related:ISPE Announces 2026 Europe Conference Keynotes, Sessions

Nearly a dozen other drug companies, including J&J, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi, AstaZeneca, Eli Lilly, Novo Nordisk, and Pfizer have signed agreements to sell some medications at discount prices on the direct-to-consumer platform, over the last several months.

Source link

Billionaire behind ‘American Factory’ firm warns of US exit amid trade friction with China

As one of the world’s largest automotive glass producers, and the subject of an Oscar-winning documentary, Fuyao Glass is a familiar name in the United States. Now, its founder has warned he is prepared to shut down his American plants if trade friction and tariffs cause severe losses.

Responding to questions regarding geopolitical risks at the company’s annual general meeting, Cao Dewang said that the company would not engage in loss-making ventures.

“How much in duties you want to impose is your business,” said the billionaire, who turns 80 next month. “If we encounter unreasonable situations, we’ll simply shut down the [US] factories.”

While Fuyao’s American roots stretch back to 1995, its presence is now anchored by its plant in Moraine, Ohio – a shuttered General Motors factory that Fuyao purchased in 2014.

The 2019 film American Factory documented the site’s transformation, tracing both its role in revitalising a depressed local economy and Cao’s harsh campaign against unionisation.

Today, Fuyao Glass employs thousands of American workers across facilities in Ohio, Illinois and South Carolina, supplying leading automotive manufacturers including General Motors, Ford and BMW in the United States, according to its website.

The company also holds the distinction of being the first Chinese firm to successfully sue the US Department of Commerce, winning a landmark case that virtually exempted Fuyao from anti-dumping duties in 2004.

09:42

Trump promises to bring US manufacturing back from China, but will his tariffs work?

Trump promises to bring US manufacturing back from China, but will his tariffs work?

Cao’s comments earlier this week – widely reported by Chinese media, including state-owned The Paper – came just over a year after US President Donald Trump launched his “Liberation Day” tariffs on major trading partners. The move ignited a renewed trade war with Beijing that saw duties on Chinese imports peak at 145 per cent before tensions de-escalated.



Source link

US manufacturing activity hits 4-year high: White House

US manufacturing is witnessing a surge across the country as the sector is growing for the third consecutive month, with key indicators showing broad strength, the White House recently said.

The Institute for Supply Management’s (ISM) key manufacturing index—which tracks factory activity across the country—registered the sector’s third straight month of expansion for its highest reading since 2022.

US manufacturing is seeing a surge as the sector is growing for the third month in a row, with key indicators showing broad strength, the White House said.
The ISM manufacturing index saw the third straight month of expansion for its highest reading since 2022.
The Federal Reserve Bank of Philadelphia’s April manufacturing index rose.
Orders for capital goods exceeded $4 billion in each month of Q4 2025.

The ISM new orders index expanded for the third consecutive month as both domestic and global buyers turn to US-made goods. The production index expanded for the fifth consecutive month and is accelerating as factories run at a pace not seen since before the Joe Biden-era slowdown, a White House release said.

The Federal Reserve Bank of Philadelphia’s manufacturing index surged in April, smashing expectations.

The manufacturing sector capped off the first quarter of 2026 with the first positive manufacturing job growth in three years. In a year, real manufacturing worker pay increased by $2,400 under President Trump after falling by $830 during President Biden’s four years in office.

The broader US economy has now expanded for 17 consecutive months, a streak of sustained growth the Biden Administration was never able to deliver.

Meanwhile, US Trade Representative Jamieson Greer testified this week before the House of Representatives Ways and Means Committee to lay out how Trump’s trade policy is delivering tangible results for American workers and their families, eliminating long-standing trade barriers abroad while reshoring jobs and production back home.

He highlighted the surge in orders for capital goods used for production, exceeding $4 billion each month of the fourth quarter of 2025.

Fibre2Fashion News Desk (DS)

Source link

Skydio to invest $3.5 billion to expand U.S. drone manufacturing

Skydio announced plans to invest $3.5 billion in the United States over the next five years to expand domestic manufacturing and research capabilities. The company said the initiative aims to strengthen supply chains and support long-term growth in the U.S. drone industry.

 

The investment is expected to create more than 2,000 jobs within Skydio and support over 3,000 additional roles across the domestic supply chain. More than $1 billion of the total funding will be directed to U.S.-based suppliers.

Skydio said it already produces more dual-use drones than any company outside China. The company has delivered over 60,000 systems to more than 3,800 customers, including public safety agencies, U.S. military branches, allied nations and commercial operators.

A central element of the expansion is the SkyForge program. This initiative is designed to support domestic production and reinforce U.S.-based manufacturing capabilities.

 

 

The company plans to open a new manufacturing facility that will be five times larger than its current site. This will mark Skydio’s fifth expansion in eight years as it responds to increased demand.

The investment will also support the development of domestic suppliers for critical components. Skydio said it will work with selected partners to co-locate production and provide access to engineering expertise.

Adam Bry, co-founder and Chief Executive Officer of Skydio, said: “U.S. innovation invented the airplane, ramped up manufacturing to win WWII, put a man on the moon, broke the sound barrier, and commercialized space travel.” He added: “Skydio has proven that American companies can compete and win in the civilian drone market against products from our adversaries.”

The company said drones have rapidly evolved into critical infrastructure tools across multiple sectors. Its systems are used in public safety, where aerial capabilities can support faster response times.

 

 

Skydio said its technology enables drones to arrive first at incident scenes in a majority of cases. In some situations, operations can be resolved without deploying additional units.

The company said the investment will reinforce domestic manufacturing of electronics and components. It also aims to strengthen secure supply chains that support national resilience.

Skydio said it will continue expanding production capacity to meet demand from public safety, national security and utility sectors. The company added that the initiative reflects a broader effort to position the United States as a leader in autonomous aerial systems.

 

Source link

AbbVie CEO Leads US$1.4bn Manufacturing Expansion

AbbVie is investing £1.1bn (US$1.4bn) in a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina, marking the company’s largest capital investment to date. The decision represents a significant strategic move by the pharmaceutical giant to expand its US manufacturing footprint into a new region.

The campus will integrate advanced manufacturing and laboratory technologies as well as AI to support the production of immunology, neuroscience and oncology medicines. AbbVie expects the facility to create 734 jobs, including engineers, scientists, manufacturing operators and laboratory technicians.

The first phase of construction will include small volume parenteral drug product manufacturing facilities, next-generation laboratories, a warehouse, administrative offices and employee wellness facilities. Small volume parenterals are sterile injectable pharmaceutical products with volumes typically less than 100ml, including vials, prefilled cartridges and prefilled syringes containing medicines for injection or infusion.

Source link

US Unveils High-tech Manufacturing Zone in Philippines Under Pax Silica to Secure AI Supply Chains

The United States announced plans on April 16 to establish a high-tech manufacturing zone in the Philippines under the Pax Silica initiative, a U.S.-led framework aimed at strengthening AI supply chains and economic security among allied nations.

The 4,000-acre industrial hub will be located in the Luzon Economic Corridor, forming part of a new “Economic Security Zone” model designed to boost advanced manufacturing and secure critical supply chains in the Indo-Pacific region.

“The Economic Security Zone is part of a broader strategy to surge production for inputs vital to U.S. supply chains,” the U.S. Department of State in a release.”

“It is expected to serve as a purpose-built platform for allied manufacturing—an investment acceleration hub where the specific industrial activities are shaped by market demand, host-country comparative advantages, and the evolving needs of the allied network.” 

According to the U.S. Embassy in Manila, Philippine trade official Ceferino S. Rodolfo signed a declaration this month formalizing the country’s participation in Pax Silica.

Success

You are now signed up for our newsletter

Success

Check your email to complete sign up

Launched in December by the United States and 13 partner countries — including Japan, India, Australia, the United Kingdom, and the United Arab Emirates — the initiative aims to build resilient semiconductor supply chains, secure critical minerals, and align economic security strategies among allies.

Countering China’s dominance in global supply chains

Analysts say the project is closely tied to efforts to reduce reliance on China-dominated supply chains and reshape global production networks.

“It looks like the U.S. is persuading the Philippines to align more closely with its bloc in the region as a counterbalance to China,” said Prof. Pooran Pandey of the Global TechnoPolitics Forum.

“If the 20th century ran on oil and steel, the 21st century runs on computers and the minerals that feed it,” said Jacob Helberg, U.S. Under Secretary for Economic Affairs, in a prior State Department statement.

“This historic declaration hails a new economic security consensus ensuring aligned partners build the AI ecosystem of tomorrow — from energy and critical minerals to high-end manufacturing and models.”

The State Department did not explicitly name China but referred to a “systematic transformation” aimed at competing with and ultimately displacing concentrated supply chains.

The Philippines’ role is seen as strategic, given its reserves of nickel, copper, chromite, and cobalt, all critical for electronics and clean energy technologies, as well as its growing labor force.

The Philippines joined Pax Silica shortly after signing a U.S.-Philippines Critical Minerals Framework on Feb. 4, reinforcing cooperation in sectors such as semiconductors, electronics, and resource extraction.

The Wall Street Journal reported that the U.S. will use the land rent-free for two years and that the facility will operate under U.S. common law with diplomatic immunity, an unprecedented arrangement for an overseas industrial hub.

Pandey said the initiative reflects broader U.S.-China geopolitical competition in the Indo-Pacific.

“China continues to remain the elephant in the room for Americans as a fast emerging superpower across the board,” he said.

An April 20 op-ed by Philippines-based outlet Dito Sa Pilipinas described the project as part of a wider global supply chain realignment driven by geopolitical rivalry.

“The industrial hub cannot be separated from the broader rivalry between the United States and China,” it said. “Countries like the Philippines are being positioned as alternative production and sourcing bases for strategic materials and technologies.”

Economic opportunities and domestic concerns in the Philippines

Experts say the project could significantly reshape the Philippines economy, bringing investment and infrastructure development.

“For the Philippines, the project promises significant economic transformation by attracting substantial foreign investment into sectors such as electronics and clean energy,” said Dr. Sampa Kundu, a New Delhi-based researcher.

“It is expected to create thousands of high-quality jobs, modernise infrastructure such as ports and rail, and position the country as a leading destination for innovation.”

Local analysts also see potential for long-term gains through deeper integration with U.S.-led industrial networks.

However, concerns remain over whether the benefits will extend broadly across the domestic economy.

“If it functions mainly as a self-contained enclave with limited spillover effects, the benefits may remain concentrated and externalized,” Dito Sa Pilipinas noted.

There are also questions about governance. Because the hub is expected to operate under U.S. common law, critics worry about limited Philippine regulatory oversight.

“The question is not just who builds and funds the hub, but who sets the rules, resolves disputes, and ultimately benefits from its operations,” the op-ed said.

Indo-Pacific geopolitics and strategic implications

The project’s location in the Luzon Economic Corridor underscores its geopolitical significance in the Indo-Pacific strategy of the United States and its allies.

Experts say the initiative reflects the emergence of economic-security blocs, where trade, technology, and defense considerations are increasingly intertwined.

“Regionally, it marks a shift toward economic-security blocs, strengthening a U.S.-aligned industrial network in the Indo-Pacific,” Kundu said.

While this could enhance resilience against global supply chain disruptions, it may also intensify geopolitical competition.

For the Philippines, the development presents both opportunity and risk.

“On one hand, the Philippines gains visibility in high-tech and strategic industries it has long tried to enter,” Dito Sa Pilipinas said. “On the other, it risks becoming overly embedded in a geopolitical competition that prioritizes strategic alignment over domestic industrial policy.”

Source link

AbbVie Invests $1.4 Billion into New Manufacturing Campus in North Carolina

AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina.

Emerging Pharma Leaders nominations are now open!

Do you know someone who can make tough decisions that continue to face manufacturers? Are they destined to change the future of pharma?

Nominate a colleague with impressive leadership and career intentions – even yourself! – for the Pharmaceutical Executive 2026 Emerging Pharma Leaders Awards.

The decision marks the company’s largest capital investment to date and its first major presence in the state.

The campus, located near Research Triangle Park, is set to integrate advanced manufacturing and laboratory technologies with artificial intelligence to support production of AbbVie’s immunology, neuroscience, and oncology medicines.1 The first phase of construction is expected to include small volume parenteral drug product manufacturing facilities for sterile injectables including vials, prefilled cartridges, and prefilled syringes, alongside next-generation laboratories, a warehouse, administrative offices, and employee wellness facilities.1

Upon complete, the Durham campus will serve as AbbVie’s U.S. center of excellence for SVP manufacturing, supplying patients both domestically and internationally.1

Construction begins this year, with completion expected by the end of 2028.

AbbVie is expecting to hire 734 people over the next four years, including engineers, scientists, manufacturing operators, and laboratory technicians, along with the development phase expecting to generate more than 2,000 construction jobs. Durham was selected due to the strength of its regional workforce and its capacity to support future expansion.

“Our investment in North Carolina represents a significant milestone for AbbVie as our largest capital investment to date and an important expansion of our manufacturing footprint into a new region of the United States,” said Robert A. Michael, chairman and chief executive officer of AbbVie. “By establishing this campus, we are strengthening our ability to support future medical breakthroughs while also creating new jobs and a long-term partnership with Durham and the State of North Carolina.”

North Carolina Governor Josh Stein welcomed the investment, saying, “When you combine our world-renowned research and innovation with a strong, thriving life sciences hub, North Carolina quickly becomes the premier location for biopharmaceutical companies to do business.”

The Durham campus is part of AbbVie’s previously announced $100 billion commitment to U.S. research, development, and capital investments over the next decade.2 The company says it has now committed more than $2.2 billion in U.S. manufacturing investment over the past 12 months, including a $745 million license agreement with Haisco, and creating more than 1,300 jobs across North Carolina, Illinois, Arizona, and Massachusetts. AbbVie currently employs approximately 29,000 people in the U.S., including more than 6,000 at its domestic manufacturing campuses.

“AbbVie’s mission is to make a remarkable impact for the patients we serve around the world through our innovative medicines,” said Robert A. Michael, chairman and chief executive officer, AbbVie. “With approximately 29,000 U.S.-based employees and products treating 16 million Americans annually, we understand the complexity and access challenges in our healthcare system.”

The investment follows a broader trend of major pharmaceutical companies expanding U.S. manufacturing capacity, driven by a combination of supply chain resilience concerns, domestic policy incentives, and growing demand for complex biologics and injectable therapies across chronic disease indications.

1. AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus AbbVie April 22, 2026 https://www.prnewswire.com/news-releases/abbvie-selects-north-carolina-for-new-1-4-billion-manufacturing-campus-302750567.html
2. AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans AbbVie January 12, 2026 https://news.abbvie.com/2026-01-12-AbbVie-and-Trump-Administration-Reach-Agreement-to-Improve-Access-and-Affordability-for-Americans

Source link

Anheuser-Busch Doubles Its Investment in US Manufacturing

Beer giant Anheuser-Busch announced on Wednesday its $600 million investment in U.S. manufacturing over two years, building on a previously announced $300 million commitment in 2025.

The beer giant announced its commitment to expanding brewery capacity, worker training, and veteran hiring, according to the company.

“By strengthening our manufacturing operations, we are creating sustainable careers–not just jobs–and investing in the people who are vital to our success,” Brendan Whitworth, CEO, Anheuser-Busch, said in a statement.

The company said it has committed to an investment in the future of its workforce by opening 15 new technical skills training centers at its facilities across the U.S. and collaborating with technical trade schools.

Through this expansion, Anheuser-Busch also plans to upskill more than 90 percent of its manufacturing workforce over the next five years, a move that builds on the more than 2,700 employees who have already received training since the opening of its Technical Excellence Center in St. Louis in 2022.

“Anheuser-Busch’s expanded investment is a commitment to the American worker and the future of our nation’s strength in manufacturing,” Jay Timmons, President and CEO, National Association of Manufacturers, said in a statement.

The beer maker also said it plans to continue helping former and current service members pursue manufacturing careers in the private sector.

The company in August 2025 committed $15 million to its flagship St. Louis brewery, which was part of the original $300 million plan, funding supply-chain infrastructure to move ingredients to the brewery and distribute beer to customers.

The company, which manufactures Michelob ULTRA, Busch Light, Budweiser and Bud Light, said it makes 99 percent of the beer it sells in the domestically in the United States.

In March, 15,000 new jobs were added in the manufacturing sector in the United States, recovering from worker losses earlier this year, according to the U.S. Bureau of Labor Statistics.

The company’s expanded commitment aligns with President Donald Trump’s push for domestic manufacturing.

According to the White House, the manufacturing sector has surged since President Donald Trump took office. Major corporations have committed billions of dollars in new investments to onshore production and create thousands of high-quality American jobs.

Automaker Stellantis announced a $13 billion investment in the United States, marking the largest single investment in the company’s history, while Whirlpool Corporation has committed a $300 million investment in its U.S. laundry manufacturing facilities. Meanwhile, the GE Aerospace Foundation announced a $30 million workforce skills training program to prepare the next generation of its U.S.-based workforce.

According to the Trump administration, the historic level of investment secured has reinforced the United States as the global leader of innovation and growth.

Source link

WesPro JCB Celebrates Grand Opening of Its Second Atlanta Area Facility : CEG

JCB photo

Cutting the ribbon on the new store (L-R) are Gareth Lumsdaine, vice president of distribution development, JCB North America; Graeme Macdonald, CEO, JCB; Wesley Scott, owner, WesPro JCB; and Richard Fox-Marrs, president and CEO, JCB North America.

WesPro JCB celebrated the grand opening of its new Norcross, Ga., facility, its second in the Atlanta area, marking a significant milestone in its continued growth and expansion across the Southeast.

The event welcomed customers, local officials and industry partners to officially open the 14,000-sq.-ft. site, designed to enhance sales experience, parts availability, service capabilities and overall support for construction and agricultural customers across metro Atlanta.

The $14 million facility, located at 5493 Goshen Springs Rd., represents the latest investment in JCB‘s expanding American network, strengthening support for customers and dealers in key United States markets.

“Our investment in facilities like WesPro JCB and our $1 billion Texas facility reflects our commitment to manufacturing in the United States and supporting American industry,” said Graeme Macdonald, CEO of JCB. “We are investing at scale to build a stronger American business that delivers equipment, supports our dealers and serves customers across construction and agriculture.”

Expanding Capabilities to Support Customers

The Norcross facility, situated on a 3-acre site along Interstate 85, is designed to improve uptime and service responsiveness for customers across the region. Strategically located along one of metro Atlanta’s busiest transportation corridors, it enhances accessibility and enables quicker response to customer needs.

The site includes a 2,000-sq.-ft. parts warehouse, 10 service bays and the capability to repair the largest JCB excavators and machinery, supporting faster diagnostics, more efficient repairs and reduced downtime.

“Our commitment to manufacturing in America for American customers goes hand in hand with investing in the facilities and dealer network that support our equipment throughout its lifecycle,” said Richard Fox-Marrs, president and CEO of JCB North America. “Facilities like WesPro’s Norcross location ensure we are delivering the service, parts availability and expertise our customers rely on long after the initial purchase.”

Expanding Presence in Key Markets

The Norcross facility is part of JCB’s expanding presence across the United States, alongside continued investment in manufacturing and dealer development in key markets. In addition to its new factory in San Antonio, Texas, JCB has established a growing dealer and warehousing presence in north Texas, southern California and Chicago, with plans for future expansion in major metropolitan areas.

“JCB has deep roots in Georgia, and WesPro is proud to be the newest branch of that continued growth,” said Wesley Scott, owner of WesPro JCB. “This investment strengthens our ability to support our customers with the sales, service and expertise they depend on every day.”

For more information, visit wesprojcb.com.

Source link